Stage IIIA Breast Cancer Terminated Phase 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0028774 (Stage IIIA Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00679029Combination Chemotherapy and Bevacizumab in Treating Women With HER2/Neu-Negative Stage II or Stage III Breast CancerTreatment